retatrutide type 2 diabetes phase 2 results 2024 2025 There are many great research studies to read on this topic! Below are a few to check out- Harris, L. H., Jastreboff, A. M., Aronne, L. J., et al. (2023). Retatrutide, a Phase 2 trial results demonstrate
Description
SGLT2i: sodium glucose cotransporter-2 inhibitors
Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO
Instead of universal withholding, the guidance emphasized shared decision-making and targeted risk reduction for patients most likely to have delayed gastric emptying, such as those in the dose-escalation phase, those with notable gastrointestinal symptoms, those on higher doses, and those with comorbid conditions that slow gastric emptying
No digestion, no waiting, just straight to your bloodstream
Rivera, F
